IPI LEGACY LIQUIDATION CO Attività
Numero di dipendenti: 160
Dirigenti
| Dirigenti | Titolo | Età | Da |
|---|---|---|---|
John D. Hoekman
FOU | Founder | 43 | 01/01/08 |
Sheena Aurora
CTO | Chief Tech/Sci/R&D Officer | - | - |
Scott Youmans
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Sarah Wille
HRO | Human Resources Officer | - | 01/01/19 |
Lynn Gold
LAW | General Counsel | 67 | 01/07/18 |
Amministratori
| Amministratori | Titolo | Età | Da |
|---|---|---|---|
Timothy Nelson
BRD | Director/Board Member | 60 | 01/02/17 |
Diane Wilfong
BRD | Director/Board Member | 62 | 17/09/19 |
David Allison
BRD | Director/Board Member | 42 | 01/06/19 |
John D. Hoekman
FOU | Founder | 43 | 01/01/08 |
Darren Cline
BRD | Director/Board Member | 59 | 12/04/23 |
Classe di azioni
| Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
|---|---|---|---|---|---|
| Azione A | 1 | 23 900 031 | 23 880 031 ( 99,92 %) | 0 | 99,92 % |
Coordinate società
Impel Pharmaceuticals, Inc.
201 Elliott Avenue West Suite 260
98119, Seattle
+206 568 1466
http://impelpharma.com
Settore
| Variaz. 1 gen. | Capi. | |
|---|---|---|
| +18,09% | 45,01 Mrd | |
| +45,32% | 40,96 Mrd | |
| -8,38% | 38,62 Mrd | |
| +34,66% | 32,6 Mrd | |
| -8,34% | 27,49 Mrd | |
| +16,10% | 27,17 Mrd | |
| +49,73% | 14,61 Mrd | |
| +36,71% | 12,95 Mrd | |
| -6,60% | 11,36 Mrd |
